Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
topical drug delivery
Pharma
FDA signs off on Leo Pharma's chronic hand eczema cream Anzupgo
Leo has scored an FDA nod that makes its JAK inhibitor Anzupgo the first therapeutic in the U.S. specifically indicated for chronic hand eczema.
Kevin Dunleavy
Jul 24, 2025 8:45am
Incyte's Opzelura scores in hidradenitis suppurativa study
Mar 11, 2024 1:58pm
Arcutis' Zoryve has snagged a 2nd dermatology nod from FDA
Dec 15, 2023 7:09pm
Leo unveils detailed results on JAK cream win in hand eczema
Oct 13, 2023 11:05am
Incyte's Opzelura hits goal in eczema trial in young kids
Jul 12, 2023 10:30am
Arcutis' topical cream goes 2 for 2 in pivotal eczema trials
Dec 13, 2022 7:55am
